Design, formulation and evaluation of nicotine chewing gum


Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Center, Isfahan University of Medical Sciences, Isfahan, Iran


Background: Nicotine replacement therapy (NRT) can help smokers to quit smoking. Nicotine chewing gum has attracted the attention from pharmaceutical industries to offer it to consumers as an easily accessible NRT product. However, the bitter taste of such gums may compromise their acceptability by patients. This study was, therefore, designed to develop 2 and 4 mg nicotine chewing gums of pleasant taste, which satisfy the consumers the most.
Materials and Methods: Nicotine, sugar, liquid glucose, glycerin, different sweetening and taste-masking agents, and a flavoring agent were added to the gum bases at appropriate temperature. The medicated gums were cut into pieces of suitable size and coated by acacia aqueous solution (2% w/v), sugar dusting, followed by acacia-sugar-calcium carbonate until a smooth surface was produced. The gums' weight variation and content uniformity were determined. The release of nicotine was studied in pH 6.8 phosphate buffer using a mastication device which simulated the mastication of chewing gum in human. The Latin Square design was used for the evaluation of organoleptic characteristics of the formulations at different stages of development. Results: Most formulations released 79-83% of their nicotine content within 20 min. Nicotine-containing sugar-coated gums in which aspartame as sweetener and cherry and eucalyptus as flavoring agents were incorporated (i.e. formulations F 19-SC and F 20-SC , respectively) had optimal chewing hardness, adhering to teeth, and plumpness characteristics, as well as the most pleasant taste and highest acceptability to smokers.
Conclusion: Taste enhancement of nicotine gums was achieved where formulations comprised aspartame as the sweetener and cherry and eucalyptus as the flavoring agents. Nicotine gums of pleasant taste may, therefore, be used as NRT to assist smokers quit smoking.


1. Mitrouska I, Bouloukaki I, Siafakas NM. Pharmacological approaches to smoking cessation. Pulm Pharmacol Ther 2007;20:220-32.  Back to cited text no. 1
2. Bernhard D, Moser C, Backovic A, Wick G. Cigarette smoke--an aging accelerator? Exp Gerontol 2007;42:160-5.  Back to cited text no. 2
3. Quit Smoking [Updated 2012 January]. Available from: http://www. quit smoking  Back to cited text no. 3
4. Thomas E, Novotng TE, Cohen JC, Yarekli A, Sweanor D, Beyer J. Smoking cessation and nicotine-replacement therapies. In Jha P, Chaloupka FJ, editors. Tabacco control in developing countries. Oxford: Oxford University Press; 2000. p. 287-307.  Back to cited text no. 4
5. Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004;43:619-32.  Back to cited text no. 5
6. Karnath B. Smoking cessation. Am J Med 2002;112:399-405.  Back to cited text no. 6
7. Kralikova E, Kozak JT, Rasmussen T, Gustavsson G, Houezec JL. Smoking cessation or reduction with nicotine replacement therapy: A placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health 2009;9:433.   Back to cited text no. 7
8. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation (Review). Cochrane Database Syst Rev 2004;3:CD000146.  Back to cited text no. 8
9. Madhav NV, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: A review. J Control Release 2009;140:2-11.  Back to cited text no. 9
10. Biradar SS, Bhagavti ST, Hukkeri VI, Rao KP, Gadad AP. Chewing gum as a drug delivery system. Scientific Journal Articles 2005. Available from:  Back to cited text no. 10
11. Surana SA. Chewing gum: A friendly oral mucosal drug delivery system. Int J Pharm Sci Rev Res 2010;4:68-71.   Back to cited text no. 11
12. Rowe RC. By gum a buccal delivery system - Private prescription: A thought-provoking tonic on the lighter side. Drug Discov Today 2003;8:617-8.  Back to cited text no. 12
13. Britt DM, Cohen LM, Collins FL, Cohen ML. Cigarette smoking and chewing gum: Response to a laboratory-induced stressor. Health Psychol 2001;20:361-8.  Back to cited text no. 13
14. Shiffman S, Cone EJ, Buchhalter AR, Henningfield JE, Rohay JM, Gitchell GJ, et al. Rapid absorption of nicotine from new nicotine gum formulations. Pharmacol Biochem Behav 2009;91:380-4.  Back to cited text no. 14
15. Pandey S, Goyani M, Devmurari V. Development, in-vitro evaluation and physical characterization of medicated chewing gum: Chlorhexidine gluconate. Der Pharmacia Lettre 2009;1:286-92.  Back to cited text no. 15
16. European Pharmacopoeia, 6 st ed. Strasbourg: Directorate for the Quality of Medicine and Health Care of the Council of Europe, 2009. p. 278.  Back to cited text no. 16
17. Kolahi Kazerani G, Ghalyani P, Varshosaz J. A study on design, formulation and effectiveness of chewing gum containing chlorhexidine gluconate in the prevention of dental plaque. J Dent Tehran Univ Med Sci 2003;16:53-8.  Back to cited text no. 17
18. Hoppu P. Saccharine sodium. In, Rowe RC, editor. Handbook of pharmaceutical excipients, 6 st ed. London: Pharmaceutical Press; 2009. P. 608-9.  Back to cited text no. 18
19. Liquorice. Wikipedia, the Free Encyclopedia. Available from: [Last Updated on 2012 Jan 27].  Back to cited text no. 19
20. Ley JP. Masking bitter taste by molecules. Chem Percept 2008;1:58-77.  Back to cited text no. 20
21. Keast RSJ. The effect of zinc on human taste perception. J Food Sci 2003;68:1871-7.  Back to cited text no. 21
22. Morjaria Y, Irwin WJ, Barnett PX, Chan RS, Conway BR. In vitro release of nicotine from chewing gum formulations. Dissolut Technol 2004;11:12-5.  Back to cited text no. 22